3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
16
Carcinoma, Non-Small-Cell Lung
8
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
2
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Urothelial Cancer
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Malignancies
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms
1
Mesothelioma, Malignant
1
Hypertension, Portal
1
Hydronephrosis
1
Hepato Cellular Carcinoma
1
Hematologic Neoplasms
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
trastuzumab biosimilar HLX02
2
ribociclib
2
pertuzumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Paclitaxel
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
Docetaxel
2
2C4 antibody
2
tucatinib
1
exemestane
1
durvalumab
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Mastectomy, Segmental
1
Mastectomy
1
Letrozole
1
Immunoglobulin G
1
Genetic Testing
1
Fulvestrant
1
Fluorodeoxyglucose F18
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage II Breast Cancer AJCC v8
×
tremelimumab
×
90 days
×
Clear all
No trials found.